RTI Surgical shareholders approved its acquisition of Paradigm Spine.
"With shareholder approval secured, we look forward to closing the acquisition and strengthening our spine portfolio with the addition of the coflex Interlaminar Stabilization device," said RTI Surgical President and CEO Camille Farhat.
The coflex device is a minimally invasive solution designed for patients with moderate to severe lumbar spinal stenosis. It has received FDA premarket approval to be performed in conjunction with decompression.
The company announced intentions to acquire Paradigm Spine in late 2018 and anticipates closing the acquisition March 8.